Riding the Employment Roller Coaster - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Riding the Employment Roller Coaster
2010 came with pay raises for those still employed and anxiety for all. This article contains bonus online material.


Pharmaceutical Technology
Volume 34, Issue 12, pp. 36-39

Job security


Figure 4: Sources of job stress (multiple responses were allowed).
Of course being employed is only part of the story. The other part of the story is how secure people feel in their jobs—and people don't feel very secure. While 53% of respondents report feeling insecure as compared with past years, insecurity runs highest in the US, where 55.3% of respondents felt insecure (15% feel more secure than they did in the past). The most secure workers live in India, where 25% of respondents feel insecure, and 37.5% feel more secure now than in years past. Half of the respondents from Western Europe feel insecure, and 54.5% of Canadian respondents feel insecure. Men and women feel almost equally insecure—with 54.2% of men, and 52.6% of women feeling insecure. Interestingly, more women—18.6%—report feeling more secure than they did in the past, as opposed to only 14.2% of men.


Figure 5: Company expansion plans.
Offering the greatest security are contract manufacturers and service providers, as 52.9% of respondents who work for these companies say their jobs are secure. Next most secure are workers in generic-drug firms, where 46.6% of respondents say their jobs are secure, followed by traditional bio/pharmaceutical companies with 39.2% feeling secure about their jobs. Biotech companies trail that with 38.9% of respondents reporting that their jobs are secure. Biotech companies also have the greatest percentage of workers who feel insecure about their jobs—38.9% of respondents from biotech companies said they feel insecure, as did 32.4% of respondents from traditional bio/pharmaceutical companies, and 27.4% of workers in contract service and manufacturing companies. Finally, only 11.1% of workers in generic-drug companies feel insecure in their jobs.


Respondents
Of course, this year the economy continued to have profound implications for workers in the pharmaceutical industry, and 11.3% of respondents reported losing their jobs because of it. Canadians suffered the heaviest job losses, as 18.2% of Canadian respondents report losing their jobs, in contrast to 12.2% of US workers, and 6.7% of Western European works. Indian workers reported 0% job losses for themselves and their colleagues due to the economy. Workers in contract service and manufacturing providers lost the most jobs—29.8% of respondents in these companies report losses, followed by 10.1% in traditional bio/pharmaceutical manufacturers, 7.5% in generic companies, and 3% in biotechnology.


In the name of innovation
Among respondents that remain employed, 30.1% say their workday has become longer, and 23.5% report that they've taken on additional functions to fill in for lost coworkers.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here